2-[3-(4-methylphenyl)-5-sulfanylidene-1H-1,2,4-triazol-4-yl]-N-[(1S,2R)-2-(trifluoromethyl)cyclohexyl]acetamide

C18H21F3N4OS — CID 95142089

IUPAC2-[3-(4-methylphenyl)-5-sulfanylidene-1H-1,2,4-triazol-4-yl]-N-[(1S,2R)-2-(trifluoromethyl)cyclohexyl]acetamide
SMILESCc1ccc(-c2n[nH]c(=S)n2CC(=O)N[C@H]2CCCC[C@H]2C(F)(F)F)cc1
InChIInChI=1S/C18H21F3N4OS/c1-11-6-8-12(9-7-11)16-23-24-17(27)25(16)10-15(26)22-14-5-3-2-4-13(14)18(19,20)21/h6-9,13-14H,2-5,10H2,1H3,(H,22,26)(H,24,27)/t13-,14+/m1/s1
InChIKeyKAAGLIXKOCJNIL-KGLIPLIRSA-N
MW398.45 g/mol
LogP4.15
Rot. Bonds4

About 2-[3-(4-methylphenyl)-5-sulfanylidene-1H-1,2,4-triazol-4-yl]-N-[(1S,2R)-2-(trifluoromethyl)cyclohexyl]acetamide

2-[3-(4-methylphenyl)-5-sulfanylidene-1H-1,2,4-triazol-4-yl]-N-[(1S,2R)-2-(trifluoromethyl)cyclohexyl]acetamide (PubChem CID 95142089) has the molecular formula C18H21F3N4OS and a molecular weight of 398.45 g/mol. Its IUPAC name is 2-[3-(4-methylphenyl)-5-sulfanylidene-1H-1,2,4-triazol-4-yl]-N-[(1S,2R)-2-(trifluoromethyl)cyclohexyl]acetamide.

Molecular Properties

Compound Name2-[3-(4-methylphenyl)-5-sulfanylidene-1H-1,2,4-triazol-4-yl]-N-[(1S,2R)-2-(trifluoromethyl)cyclohexyl]acetamide
PubChem CID95142089
Molecular FormulaC18H21F3N4OS
Molecular Weight398.45 g/mol
Exact Mass398.14
IUPAC Name2-[3-(4-methylphenyl)-5-sulfanylidene-1H-1,2,4-triazol-4-yl]-N-[(1S,2R)-2-(trifluoromethyl)cyclohexyl]acetamide
SMILESCc1ccc(-c2n[nH]c(=S)n2CC(=O)N[C@H]2CCCC[C@H]2C(F)(F)F)cc1
InChIInChI=1S/C18H21F3N4OS/c1-11-6-8-12(9-7-11)16-23-24-17(27)25(16)10-15(26)22-14-5-3-2-4-13(14)18(19,20)21/h6-9,13-14H,2-5,10H2,1H3,(H,22,26)(H,24,27)/t13-,14+/m1/s1
InChIKeyKAAGLIXKOCJNIL-KGLIPLIRSA-N
XLogP4.15
TPSA62.71 Ų
H-Bond Donors2
H-Bond Acceptors4
Rotatable Bonds4
Heavy Atoms27
Complexity

Lipinski Rule of Five

Passes Rule of Five

RuleValue
MW ≤ 500398.45
LogP ≤ 54.15
H-Bond Donors ≤ 52
H-Bond Acceptors ≤ 104

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Thiocarbonyl_group', 'substructure': 'N/A'}

Analyze 2-[3-(4-methylphenyl)-5-sulfanylidene-1H-1,2,4-triazol-4-yl]-N-[(1S,2R)-2-(trifluoromethyl)cyclohexyl]acetamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 2-[3-(4-methylphenyl)-5-sulfanylidene-1H-1,2,4-triazol-4-yl]-N-[(1S,2R)-2-(trifluoromethyl)cyclohexyl]acetamide?
The IUPAC name of 2-[3-(4-methylphenyl)-5-sulfanylidene-1H-1,2,4-triazol-4-yl]-N-[(1S,2R)-2-(trifluoromethyl)cyclohexyl]acetamide (CID 95142089) is 2-[3-(4-methylphenyl)-5-sulfanylidene-1H-1,2,4-triazol-4-yl]-N-[(1S,2R)-2-(trifluoromethyl)cyclohexyl]acetamide.
What is the SMILES notation for 2-[3-(4-methylphenyl)-5-sulfanylidene-1H-1,2,4-triazol-4-yl]-N-[(1S,2R)-2-(trifluoromethyl)cyclohexyl]acetamide?
The canonical SMILES for 2-[3-(4-methylphenyl)-5-sulfanylidene-1H-1,2,4-triazol-4-yl]-N-[(1S,2R)-2-(trifluoromethyl)cyclohexyl]acetamide is Cc1ccc(-c2n[nH]c(=S)n2CC(=O)N[C@H]2CCCC[C@H]2C(F)(F)F)cc1.
What is the InChIKey of 2-[3-(4-methylphenyl)-5-sulfanylidene-1H-1,2,4-triazol-4-yl]-N-[(1S,2R)-2-(trifluoromethyl)cyclohexyl]acetamide?
The InChIKey is KAAGLIXKOCJNIL-KGLIPLIRSA-N. The full InChI is InChI=1S/C18H21F3N4OS/c1-11-6-8-12(9-7-11)16-23-24-17(27)25(16)10-15(26)22-14-5-3-2-4-13(14)18(19,20)21/h6-9,13-14H,2-5,10H2,1H3,(H,22,26)(H,24,27)/t13-,14+/m1/s1.
What are the key properties of 2-[3-(4-methylphenyl)-5-sulfanylidene-1H-1,2,4-triazol-4-yl]-N-[(1S,2R)-2-(trifluoromethyl)cyclohexyl]acetamide?
2-[3-(4-methylphenyl)-5-sulfanylidene-1H-1,2,4-triazol-4-yl]-N-[(1S,2R)-2-(trifluoromethyl)cyclohexyl]acetamide has a molecular weight of 398.45 g/mol, XLogP of 4.15, 4 rotatable bonds, 2 hydrogen bond donors, and 4 hydrogen bond acceptors.
Where does this data come from?
All data for 2-[3-(4-methylphenyl)-5-sulfanylidene-1H-1,2,4-triazol-4-yl]-N-[(1S,2R)-2-(trifluoromethyl)cyclohexyl]acetamide is sourced from PubChem (CID 95142089), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).